As of Feb 24
| +0.0151 / +1.66%|
The 1 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +548.58% increase from the last price of 0.93.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.